When weight reduction exceeds approximately 1.5 kg per week during early therapy, clinicians should remain alert
So its been studied in inflammatory bowel diseases like Crohns disease and ulcerative colitis, ankylosing spondylitis, multiple sclerosis, lupus, psoriasis, lichen planus, type 1 diabetes, and Hashimotos [disease], fibrositis
Lancet 2006
Liraglutide enhances the effect of checkpoint blockade in lung and liver cancers through the inhibition of neutrophil extracellular traps
Jia W, Li Y, Cheung KCP, et al
Dry mouth with semaglutide often appears alongside other oral symptoms